The phrase "a blocking agent in the" is correct and usable in written English.
It can be used in scientific or medical contexts to describe a substance that inhibits or prevents a specific action or process.
Example: "The study focused on the effects of a blocking agent in the treatment of hypertension."
Alternatives: "an inhibitor in the" or "a suppressor in the".
Non-specific binding or low background noise in an ELISA system has been attributed to the use of sera as a blocking agent in ELISA systems [ 42].
In PU industry, this alcohol is widely used as blocking agent in the preparation of polyisocyanate resins offering waterborne coatings with high stability.
The preferred neuromuscular blocking agent in the absence of contraindications (eg, hyperkalaemia, burn injury more than 24 h earlier, spinal lesion or allergy) is succinylcholine in a dosage of 1 mg/kg.
Nevertheless, in agreement with international 38 and French guidelines, 39 the following two principles are applied: The preferred neuromuscular blocking agent in the absence of contraindications (eg, hyperkalaemia, burn injury more than 24 h earlier, spinal lesion or allergy) is succinylcholine in a dosage of 1 mg/kg.
BSA was used as the blocking agent in the ELISA, and the ODs given for binding of serum IgG to BSA alone were subtracted from the ODs for all candidate antigens; there was no significant difference in binding to BSA by IgG in CS, S and NS sera.
In this study, we retrospectively analyzed data from 14 patients who received sugammadex due to insufficient decurarisation (TOF < 0.9) following neostigmine administration for postoperative reversal of the effects of neuromuscular blocking agents in the operating rooms of a university and a state hospital between June , 2012 and January, 2014.
Although the use of neuromuscular blocking agents in the ICU is still a matter of ongoing debate, they continue to be frequently used.
Electroconvulsive therapy was performed using succinylcholine and rocuronium as the neuromuscular blocking agents in the first seven and latter six treatments, respectively.
Other differences included the use of neuromuscular blocking agents in the ICP group and furosemide in the exam group.
